- Home
- AMPY vs GNFT Comparison
AMPY vs GNFT Comparison
Compare AMPY & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPY
- GNFT
- Stock Information
- Founded
- AMPY 2011
- GNFT 1999
- Country
- AMPY United States
- GNFT France
- Employees
- AMPY N/A
- GNFT N/A
- Industry
- AMPY Oil & Gas Production
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMPY Energy
- GNFT Health Care
- Exchange
- AMPY Nasdaq
- GNFT Nasdaq
- Market Cap
- AMPY 186.5M
- GNFT 216.7M
- IPO Year
- AMPY 2011
- GNFT 2019
- Fundamental
- Price
- AMPY $4.95
- GNFT $3.96
- Analyst Decision
- AMPY Strong Buy
- GNFT Strong Buy
- Analyst Count
- AMPY 1
- GNFT 2
- Target Price
- AMPY $11.00
- GNFT $10.00
- AVG Volume (30 Days)
- AMPY 1.3M
- GNFT 6.3K
- Earning Date
- AMPY 11-05-2025
- GNFT 09-22-2025
- Dividend Yield
- AMPY N/A
- GNFT N/A
- EPS Growth
- AMPY N/A
- GNFT N/A
- EPS
- AMPY N/A
- GNFT N/A
- Revenue
- AMPY $275,827,100.00
- GNFT $52,994,715.00
- Revenue This Year
- AMPY N/A
- GNFT $3.14
- Revenue Next Year
- AMPY N/A
- GNFT N/A
- P/E Ratio
- AMPY N/A
- GNFT N/A
- Revenue Growth
- AMPY N/A
- GNFT N/A
- 52 Week Low
- AMPY $2.27
- GNFT $2.55
- 52 Week High
- AMPY $7.23
- GNFT $5.81
- Technical
- Relative Strength Index (RSI)
- AMPY 57.89
- GNFT 46.15
- Support Level
- AMPY $4.39
- GNFT $3.80
- Resistance Level
- AMPY $4.72
- GNFT $4.24
- Average True Range (ATR)
- AMPY 0.25
- GNFT 0.17
- MACD
- AMPY 0.03
- GNFT -0.04
- Stochastic Oscillator
- AMPY 76.59
- GNFT 41.72
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.